Skip to content
value.today

PharmaEngine, Inc. vs Regenxbio Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Regenxbio Inc. is the larger company by market value: $513 M against $220 M for PharmaEngine, Inc., 2.3 times as much (market caps of Nov 19, 2026 for PharmaEngine, Inc. and Oct 6, 2026 for Regenxbio Inc.).

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

042841271692020202120222023202420252026PharmaEngine, Inc. 67Regenxbio Inc. 35

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Regenxbio Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasurePharmaEngine, Inc.
4162.TWO · #15,893 in the world
Regenxbio Inc.
RGNX · #12,428 in the world
Profile
Country🇹🇼 Taiwan🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$220 M$513 M
Revenue—$170 M
Net income—$-194 M
Employees—372
Valuation
Price to sales—3.3×
Price to book—5.0×
Free cash flow yield—-24.6%
Profitability
Operating margin—-94.6%
Net margin—-113.8%
Return on equity—-107.0%
Growth
Revenue growth—104.5%
Revenue growth, 3 years a year—14.8%
Cash
Free cash flow margin—-74.1%
Altman Z-score zone—distress
Data as ofMarket cap Nov 2026Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, PharmaEngine, Inc. or Regenxbio Inc.?

Regenxbio Inc. is the larger company by market value: $513 M against $220 M for PharmaEngine, Inc., 2.3 times as much (market caps of Nov 19, 2026 for PharmaEngine, Inc. and Oct 6, 2026 for Regenxbio Inc.).

Sources#

Every figure on this page comes from these, with the date shown next to it.